Quick Answer
MACROGENICS INC reported Total Revenue of $149.50 million for fiscal year 2025.
MACROGENICS INC — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $149.50M -0.3% |
$149.96M +155.3% |
$58.75M -61.3% |
$151.94M +96.2% |
$77.45M -26.2% |
$104.88M +63.4% |
| Net Income | -$74.62M -11.4% |
-$66.97M -639.3% |
-$9.06M +92.4% |
-$119.76M +40.7% |
-$202.12M -55.8% |
-$129.74M +14.5% |
| Diluted EPS | -$1.18 -10.3% |
-$1.07 -613.3% |
-$0.15 +92.3% |
-$1.95 +42.1% |
-$3.37 -36.4% |
-$2.47 |
| Total Assets | $256.85M -1.8% |
$261.65M -12.3% |
$298.42M +6.4% |
$280.47M -16.3% |
$335.25M -11.5% |
$378.74M +21.2% |
| Cash and Equivalents | $57.22M -68.7% |
$182.84M +81.1% |
$100.96M -7.3% |
$108.88M -11.8% |
$123.47M -31.8% |
$181.13M +43.2% |
| Stockholders Equity | $55.59M -52.1% |
$116.06M -24.0% |
$152.61M +7.5% |
$142.01M -40.7% |
$239.62M -19.0% |
$295.88M +28.3% |
| R&D Expense | $147.17M -16.9% |
$177.19M +6.4% |
$166.58M -19.5% |
$207.03M -3.5% |
$214.58M +11.1% |
$193.20M -1.1% |
| Operating Income | -$72.84M +34.1% |
-$110.58M +34.3% |
-$168.24M -38.6% |
-$121.42M +40.1% |
-$202.79M -54.7% |
-$131.06M +26.0% |
| Shares Outstanding | 63.32M +0.8% |
62.82M +1.2% |
62.07M +0.6% |
61.70M +0.6% |
61.31M +9.0% |
56.24M +14.9% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $72.84M | -34.2% | +227.5% |
| Net Income | September 30, 2025 | $16.82M | -70.1% | +146.4% |
| Diluted EPS | September 30, 2025 | $0.27 | -70.0% | +147.4% |
| Total Assets | September 30, 2025 | $270.76M | +2.4% | +10.3% |
| Cash and Equivalents | September 30, 2025 | $80.13M | -55.4% | -38.7% |
| Stockholders Equity | September 30, 2025 | $67.00M | -44.2% | +43.7% |
| R&D Expense | September 30, 2025 | $32.71M | -19.3% | -19.8% |
| Operating Income | September 30, 2025 | $18.64M | -65.6% | +150.7% |
| Shares Outstanding | September 30, 2025 | 63.26M | +0.8% | +0.1% |
- MACROGENICS INC reported Total Revenue of $149.50 million for fiscal year 2025.
- MACROGENICS INC showed a decrease of -0.3% in Total Revenue compared to the prior fiscal year.
- MACROGENICS INC reported Net Income of -$74.62 million for fiscal year 2025.
- MACROGENICS INC showed a decrease of -11.4% in Net Income compared to the prior fiscal year.
- MACROGENICS INC reported Diluted EPS of $1.18 per share (loss) for fiscal year 2025.
- MACROGENICS INC showed a decrease of -10.3% in Diluted EPS compared to the prior fiscal year.
- MACROGENICS INC reported Total Assets of $256.85 million for fiscal year 2025.
- MACROGENICS INC showed a decrease of -1.8% in Total Assets compared to the prior fiscal year.
- MACROGENICS INC reported Cash and Equivalents of $57.22 million for fiscal year 2025.
- MACROGENICS INC showed a decrease of -68.7% in Cash and Equivalents compared to the prior fiscal year.
- MACROGENICS INC reported Stockholders Equity of $55.59 million for fiscal year 2025.
- MACROGENICS INC showed a decrease of -52.1% in Stockholders Equity compared to the prior fiscal year.
- MACROGENICS INC reported R&D Expense of $147.17 million for fiscal year 2025.
- MACROGENICS INC showed a decrease of -16.9% in R&D Expense compared to the prior fiscal year.
- MACROGENICS INC reported Operating Income of -$72.84 million for fiscal year 2025.
- MACROGENICS INC showed an increase of +34.1% in Operating Income compared to the prior fiscal year.
- MACROGENICS INC reported Shares Outstanding of 63.32 million shares for fiscal year 2025.
- MACROGENICS INC showed an increase of +0.8% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: